118 related articles for article (PubMed ID: 2642482)
1. Solubilization of prostacyclin membrane receptors from human platelets.
Tsai AL; Hsu MJ; Vijjeswarapu H; Wu KK
J Biol Chem; 1989 Jan; 264(1):61-7. PubMed ID: 2642482
[TBL] [Abstract][Full Text] [Related]
2. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
3. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
[TBL] [Abstract][Full Text] [Related]
4. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S
Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758
[TBL] [Abstract][Full Text] [Related]
5. Interaction between platelet receptor and iloprost isomers.
Tsai AL; Vijjeswarapu H; Wu KK
Biochim Biophys Acta; 1988 Jul; 942(2):220-6. PubMed ID: 2456096
[TBL] [Abstract][Full Text] [Related]
6. Human prostacyclin platelet receptors and platelet lipid composition.
Modesti PA; Abbate R; Prisco D; Gensini GF
J Lipid Mediat; 1990; 2(6):309-15. PubMed ID: 2133274
[TBL] [Abstract][Full Text] [Related]
7. Investigation of selective [3H]iloprost binding sites on human platelet membranes.
Steurer G; Jankovic B; Ettl K; Schernthaner G
Prog Clin Biol Res; 1987; 242():25-34. PubMed ID: 2444987
[No Abstract] [Full Text] [Related]
8. Internalization and down-regulation of the prostacyclin receptor in human platelets.
Giovanazzi S; Accomazzo MR; Letari O; Oliva D; Nicosia S
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):71-7. PubMed ID: 9224631
[TBL] [Abstract][Full Text] [Related]
9. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
Eggerman TL; Andersen NH; Robertson RP
J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
[TBL] [Abstract][Full Text] [Related]
10. The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cells.
Hall JM; Strange PG
Biosci Rep; 1984 Nov; 4(11):941-8. PubMed ID: 6084527
[TBL] [Abstract][Full Text] [Related]
11. Solubilization and purification of the prostaglandin E2 receptor from cardiac sarcolemma.
Michalak M; Wandler EL; Strynadka K; Catena R; Liu HJ; Olley PM
Biochim Biophys Acta; 1992 Nov; 1111(2):247-55. PubMed ID: 1329962
[TBL] [Abstract][Full Text] [Related]
12. Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets.
Burch RM; Mais DE; Saussy DL; Halushka PV
Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7434-8. PubMed ID: 2997791
[TBL] [Abstract][Full Text] [Related]
13. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
[TBL] [Abstract][Full Text] [Related]
14. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets.
Dutta-Roy AK; Sinha AK
J Biol Chem; 1987 Sep; 262(26):12685-91. PubMed ID: 2887571
[TBL] [Abstract][Full Text] [Related]
15. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
Parent CA; Lagarde M; Venton DL; Le Breton GC
J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390
[TBL] [Abstract][Full Text] [Related]
16. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
[TBL] [Abstract][Full Text] [Related]
17. Regulation of PGI2 activity by serum proteins: serum albumin but not high density lipoprotein is the PGI2 binding and stabilizing protein in human blood.
Tsai AL; Hsu MJ; Patsch W; Wu KK
Biochim Biophys Acta; 1991 Dec; 1115(2):131-40. PubMed ID: 1764464
[TBL] [Abstract][Full Text] [Related]
18. [3H]iloprost and prostaglandin E2 compete for the same receptor site on cardiac sarcolemmal membranes.
Lerner RW; Lopaschuk GD; Catena RC; Olley PM
Biochim Biophys Acta; 1992 Apr; 1105(2):189-92. PubMed ID: 1375098
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets.
Fisch A; Tobusch K; Veit K; Meyer J; Darius H
Circulation; 1997 Aug; 96(3):756-60. PubMed ID: 9264479
[TBL] [Abstract][Full Text] [Related]
20. Platelet PGI2-receptor behaviour change after treatment with acetylsalicylic acid in healthy volunteers.
Böhm T; Virgolini I; Sinzinger H
Agents Actions Suppl; 1992; 37():197-203. PubMed ID: 1632294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
